Pirfenidone: a potential new therapy for restrictive allograft syndrome?
Am J Transplant
; 13(11): 3035-40, 2013 Nov.
Article
en En
| MEDLINE
| ID: mdl-24102752
ABSTRACT
This case report describes the evolution of pulmonary function findings (FVC, FEV1 and TLC) and CT features with pirfenidone treatment for restrictive allograft syndrome following lung transplantation. Furthermore, we herein report hypermetabolic activity on (18) F-FDG PET imaging in this setting, which could indicate active fibroproliferation and pleuroparenchymal remodeling. These findings may warrant further investigation.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Complicaciones Posoperatorias
/
Fibrosis Pulmonar
/
Piridonas
/
Antiinflamatorios no Esteroideos
/
Trasplante de Pulmón
/
Enfisema
Tipo de estudio:
Etiology_studies
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Transplant
Asunto de la revista:
TRANSPLANTE
Año:
2013
Tipo del documento:
Article
País de afiliación:
Bélgica